Sofimac Investment Managers
Sofimac Investment Managers is a venture capital firm that provides financial support to SMEs for medium- and long-term development.
Business Model:
Revenue: $13.7M
Employees: 2-10
Rankings
Industries / Tags:
Detailed Sofimac Investment Managers Information
Geographic Data
Address: 24 avenue of Agriculture
City: Clermont-Ferrand
State: auvergne
Zip: 63100
Country: FR
Financial Info
Stage:
Raised Last:
$0
Raised Total:$0
Social
Facebook
Linkedin
Crunchbase
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
Acteur incontournable du capital risque de proximité, SOFIMAC PARTNERS accompagne depuis maintenant plus de 30 ans les PME régionales dans le financement de leur développement à moyen / long terme. Répondant à la problématique de sous capitalisation des PME françaises, SOFIMAC PARTNERS intervient en fonds propres aux côtés des chefs d’entreprises quelle que soit leur problématique : Création, Développement, Transmission. Gérant 200 M€ d’actifs au travers de 16 fonds (FCPR, FCPI, SCR, FIP,…), notre groupe réalise ses investissements sur une grande variété de secteurs, couvrant aussi bien les activités traditionnelles que technologiques (chimie verte, éolien, chaudronnerie aéronautique, e-commerce, édition de logiciel, médecine nucléaire etc…)
Contact Phone:
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 1/2020 | Snowleader | Venture Round | 0 |
| 9/2013 | Perfect Memory | Seed Round | 600k |
| 3/2015 | ADDIPLAST Sas | Venture Round | - |
| 7/2013 | Alpwise | Private Equity Round | 979.5k |
| 10/2016 | Glomeria Therapeutics | Grant | 3.2M |
| 11/2016 | Aston Medical | Seed Round | 264.8k |
| 3/2009 | IPM France | Venture Round | 1.3M |
| 7/2014 | ISORG | Venture Round | 8.7M |
| 1/2010 | Glycode | Series B | 4.3M |
| 5/2013 | ElsaLys Biotech | Series A | 0 |
| 4/2012 | Jet Metal Technologies | Venture Round | 1.7M |
| 4/2015 | APTE SA | Venture Round | - |
| 10/2013 | Lytess | Venture Round | - |
| 7/2010 | Allegorithmic | Series B | 1.9M |
| 11/2010 | ExoTIC Systems | Venture Round | - |
| 9/2016 | Tunetoo | Venture Round | 1.1M |
| 12/2014 | BioFilm Control | Venture Round | 3.7M |
| 11/2014 | Theranexus | Seed Round | 4.5M |
| 12/2018 | Blue Valet | Venture Round | 0 |
| 4/2018 | Ideol Offshore | Venture Round | 0 |
| 4/2018 | Uavia | Seed Round | 0 |
| 3/2015 | Amolyt Pharma | Venture Round | 1.9M |
| 4/2018 | Eurekam | Venture Round | 1.8M |
| 9/2011 | Laboratoire Precilens | Venture Round | 4.1M |
| 1/2008 | XL Group | Post-IPO Equity | 1.5M |
| 1/2011 | CenterVue SpA | Private Equity Round | - |
| 3/2017 | Whisperies | Seed Round | 609.4k |
| 3/2015 | Search&s;XPR Inc. | Venture Round | 2.1M |
| 9/2014 | Primo1D | Venture Round | 3.9M |
| 10/2010 | CellMade | Funding Round | 2.3M |
| 9/2017 | Diabeloop | Series A | 0 |
| 4/2020 | Mob-Energy | Seed Round | 0 |
| 2/2014 | Microphyt | Private Equity Round | 2.8M |
| 1/2011 | Filedanstachambre | Venture Round | 1.1M |
| 12/2016 | Aston - SEM (Groupe Acropole) | Seed Round | 268k |
| 5/2016 | Ixaltis | Venture Round | 8M |
| 10/2012 | Biom&s;Up | Series B | 0 |
| 12/2013 | Axess Vision Technology | Series B | 0 |
| 10/2018 | Bulane | Series B | - |
| 2/2017 | Care Labs | Series A | 0 |
| 1/2013 | CNSE S.A.S. | Venture Round | - |
| 1/2011 | Brea System SAS | Venture Round | - |
| 11/2007 | Wirecom Technologies | Series B | 5.8M |
| 3/2014 | Cosmo Tech | Series A | 5.2M |
| 6/2017 | Cosmo Tech | Convertible Note | 3.3M |
| 3/2016 | FineHeart | Series A | 7.2M |
| 11/2015 | Advanced Perfusion Diagnostics | Seed Round | 1.7M |
| 7/2016 | eLichens | Venture Round | 0 |
| 5/2016 | Ideol Offshore | Venture Round | 3.4M |
| 1/2006 | METabolic EXplorer | Series C | 6.1M |
| 11/2000 | METabolic EXplorer | Series A | 1.3M |
| 1/2013 | Eydo Pharma | Venture Round | - |
| 4/2012 | AREM | Venture Round | 1.3M |
| 9/2005 | EFFEMINS GROUP | Venture Round | - |
| 4/2014 | Echodia S.A.S | Seed Round | 550.6k |
| 7/2013 | Aciers Coste SA | Venture Round | - |
| 4/2017 | Blue Valet | Venture Round | 2M |
| 3/2009 | Aptys Pharmaceuticals SAS, | Venture Round | - |
| 2/2016 | AFYREN | Venture Round | 556.3k |
| 1/2014 | Groupe Villemain | Venture Round | - |
| 6/2011 | Danesi Industries | Venture Round | - |
| 5/2000 | Graitec | Series A | - |
| 3/2016 | Valbiotis | Seed Round | 2M |
| 9/2017 | Woom GmbH | Seed Round | 300k |
| 8/2015 | Bulane | Series A | 2.7M |
| 12/2012 | Laboratoires Cyclopharma SA | Venture Round | - |
| 11/2016 | Advanced Perfusion Diagnostics | Series A | 3M |
| 5/2013 | Effidence | Venture Round | - |
| 6/2013 | INDATECH - Chauvin Arnoux Group | Venture Round | 600k |
| 5/2016 | Arioneo | Seed Round | 1.2M |
| 1/2013 | METHAJOULE | Seed Round | - |
| 3/2016 | SA Galalitum | Venture Round | 198.3k |
| 4/2020 | Mob-Energy | Seed Round | 0 |
| 1/2020 | Snowleader | Venture Round | 0 |
| 12/2018 | Blue Valet | Venture Round | 0 |
| 10/2018 | Bulane | Series B | - |
| 4/2018 | Ideol Offshore | Venture Round | 0 |
| 4/2018 | Uavia | Seed Round | 0 |
| 4/2018 | Eurekam | Venture Round | 0 |
| 9/2017 | Diabeloop | Series A | 0 |
| 9/2017 | Woom GmbH | Seed Round | 0 |
| 6/2017 | Cosmo Tech | Convertible Note | 0 |
Startup Industries
Startup Locations
Portfolio Current Status
Portfolio Employee Count
| Name | Price |
|---|
| Name | Size | Announced Date |
|---|
